David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
HSBC
HSBC
$355B
| $751K | ﹤0.01% |
+18,719
| New | +$754K |
|
|
DNKN
2727
PUT
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $751K | ﹤0.01% |
10,000
| – | – |
|
|
ONIT
2728
Onity Group
ONIT
$288M
| $750K | ﹤0.01% |
27,473
+6,346
| +30% | +$179K |
|
2729
Revvity
RVTY
$14.1B
| $744K | ﹤0.01% |
+7,726
| New | +$696K |
|
2730
Natural Gas Services Group
NGS
$448M
| $741K | ﹤0.01% |
42,791
-3,409
| -7% | -$60.8K |
|
|
MACK
2731
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $741K | ﹤0.01% |
135,543
+65,480
| +93% | +$301K |
|
2732
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
| $738K | ﹤0.01% |
9,425
| – | – |
|
|
CRON
2733
CALL
Cronos Group
CRON
$1.31B
| $737K | ﹤0.01% |
40,000
| – | – |
|
2734
PUT
Wabtec
WAB
$50.8B
| $737K | ﹤0.01% |
+10,000
| New | +$721K |
|
|
AKS
2735
DELISTED
AK Steel Holding Corp
AKS
| $735K | ﹤0.01% |
267,219
-122,987
| -32% | -$349K |
|
2736
Federal Agricultural Mortgage
AGM
$2.37B
| $734K | ﹤0.01% |
10,128
+3,497
| +53% | +$255K |
|
2737
PUT
Standex International
SXI
$3.7B
| $734K | ﹤0.01% |
10,000
| – | – |
|
|
HSKA
2738
DELISTED
Heska Corp
HSKA
| $734K | ﹤0.01% |
8,626
+4,676
| +118% | +$422K |
|
|
CMA
2739
CALL
DELISTED
Comerica
CMA
| $733K | ﹤0.01% |
10,000
-13,700
| -58% | -$1.1M |
|
|
CYBR
2740
DELISTED
CyberArk
CYBR
| $733K | ﹤0.01% |
6,154
-7,150
| -54% | -$684K |
|
2741
Farmers National Banc Corp
FMNB
$928M
| $733K | ﹤0.01% |
53,172
-1,853
| -3% | -$25.6K |
|
2742
PUT
Ternium
TX
$10.8B
| $732K | ﹤0.01% |
26,900
-5,300
| -16% | -$154K |
|
|
SEI
2743
Solaris Energy Infrastructure
SEI
$3.41B
| $731K | ﹤0.01% |
+44,493
| New | +$683K |
|
2744
PUT
EnerSys
ENS
$6.96B
| $730K | ﹤0.01% |
+11,200
| New | +$846K |
|
2745
PUT
PG&E
PCG
$40.1B
| $730K | ﹤0.01% |
41,000
+4,900
| +14% | +$79.2K |
|
|
WIFI
2746
DELISTED
Boingo Wireless, Inc.
WIFI
| $729K | ﹤0.01% |
31,314
+6,801
| +28% | +$155K |
|
2747
Bassett Furniture
BSET
$165M
| $728K | ﹤0.01% |
44,379
-3,049
| -6% | -$58K |
|
2748
Copa Holdings
CPA
$5.99B
| $728K | ﹤0.01% |
9,035
-38,651
| -81% | -$3.4M |
|
2749
Myers Industries
MYE
$1.25B
| $727K | ﹤0.01% |
42,488
-800
| -2% | -$13.6K |
|
|
BT
2750
DELISTED
BT Group plc (ADR)
BT
| $726K | ﹤0.01% |
49,078
+35,181
| +253% | +$527K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.